Selection of endometrial carcinomas for p53 immunohistochemistry based on nuclear features
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Selection of endometrial carcinomas for
p53
immunohistochemistry based on nuclear features
Authors
Keywords
-
Journal
Journal of Pathology Clinical Research
Volume 8, Issue 1, Pages 19-32
Publisher
Wiley
Online
2021-10-02
DOI
10.1002/cjp2.243
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- p53abn Endometrial Cancer: understanding the most aggressive endometrial cancers in the era of molecular classification
- (2021) Amy Jamieson et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta‐analysis
- (2021) Jessica N. McAlpine et al. CANCER
- Are we confident treating pT1a G1 lymphovascular space invasion-negative patients (with myometrial invasion) with chemoradiotherapy on the basis of p53abn?
- (2021) Anna Merlotti et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Implementation of the 2021 molecular ESGO/ESTRO/ESP risk groups in endometrial cancer
- (2021) Sara Imboden et al. GYNECOLOGIC ONCOLOGY
- Equivalent Survival of p53 Mutated Endometrial Endometrioid Carcinoma Grade 3 and Endometrial Serous Carcinoma
- (2020) Mary Anne Brett et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma
- (2020) Pauline Krämer et al. CLINICAL CANCER RESEARCH
- Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy
- (2020) Alicia León-Castillo et al. JOURNAL OF CLINICAL ONCOLOGY
- Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses
- (2020) Eun Young Kang et al. MODERN PATHOLOGY
- Molecularly Classified Uterine FIGO Grade 3 Endometrioid Carcinomas Show Distinctive Clinical Outcomes But Overlapping Morphologic Features
- (2020) Amy Joehlin-Price et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
- (2020) Nicole Concin et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- The Many Uses of p53 Immunohistochemistry in Gynecological Pathology: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual9 Meeting
- (2020) Martin Köbel et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study
- (2019) Melina Arnold et al. LANCET ONCOLOGY
- p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies
- (2019) Naveena Singh et al. JOURNAL OF PATHOLOGY
- Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas
- (2019) Alicia León‐Castillo et al. JOURNAL OF PATHOLOGY
- Interpretation of somatic POLE mutations in endometrial carcinoma
- (2019) Alicia León‐Castillo et al. JOURNAL OF PATHOLOGY
- Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups
- (2018) Tjalling Bosse et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series
- (2018) S Kommoss et al. ANNALS OF ONCOLOGY
- Interpretation of P53 Immunohistochemistry in Endometrial Carcinomas
- (2018) Martin Köbel et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Letter in response to: McAlpine J, Leon-Castillo A, Bosse T. The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses. J Pathol 2018; 244: 538-549
- (2018) Martin Köbel et al. JOURNAL OF PATHOLOGY
- The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses
- (2018) Jessica McAlpine et al. JOURNAL OF PATHOLOGY
- Targeted Molecular and Immunohistochemical Analyses of Endometrial Clear Cell Carcinoma Show that POLE Mutations and DNA Mismatch Repair Protein Deficiencies are Uncommon
- (2018) Nick Baniak et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- High-grade Endometrial Carcinomas
- (2018) Rajmohan Murali et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas
- (2016) Mackenzie Coatham et al. MODERN PATHOLOGY
- Molecular Analysis of Mixed Endometrial Carcinomas Shows Clonality in Most Cases
- (2015) Martin Köbel et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Canadian high risk endometrial cancer (CHREC) consortium: Analyzing the clinical behavior of high risk endometrial cancers
- (2015) Alon D. Altman et al. GYNECOLOGIC ONCOLOGY
- POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium
- (2014) Bo Meng et al. GYNECOLOGIC ONCOLOGY
- Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations
- (2014) Yaser R Hussein et al. MODERN PATHOLOGY
- Histotype-Genotype Correlation in 36 High-grade Endometrial Carcinomas
- (2013) Lien N. Hoang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Reproducibility of histological cell type in high-grade endometrial carcinoma
- (2013) Guangming Han et al. MODERN PATHOLOGY
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search